See the DrugPatentWatch profile for Diclofenac
Diclofenac sodium extended-release (EC) is an oral nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. It is available in various formulations, including extended-release tablets.
How does Diclofenac Sodium EC work?
Diclofenac sodium EC works by inhibiting the cyclooxygenase (COX) enzymes, COX-1 and COX-2. These enzymes are responsible for the production of prostaglandins, which are chemicals that contribute to inflammation, pain, and fever [1]. By blocking prostaglandin synthesis, diclofenac sodium EC reduces these symptoms.
What conditions is Diclofenac Sodium EC used for?
Diclofenac sodium EC is prescribed to manage pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis [2].
What are the potential side effects of Diclofenac Sodium EC?
Common side effects can include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain. Some individuals may experience dizziness, headache, or rash. More serious side effects, though less common, can include stomach ulcers, bleeding, heart problems, kidney problems, and allergic reactions [2].
How does Diclofenac Sodium differ from other NSAIDs?
Diclofenac sodium is a non-selective COX inhibitor, meaning it affects both COX-1 and COX-2 enzymes. Some NSAIDs are designed to be more selective for COX-2, which may offer a different side effect profile, particularly regarding gastrointestinal risks. The extended-release formulation of diclofenac sodium is designed to release the medication slowly over time, potentially allowing for less frequent dosing compared to immediate-release versions.
When does the patent for Diclofenac Sodium EC expire?
Information regarding specific patent expirations for diclofenac sodium extended-release formulations can be found on DrugPatentWatch.com [3]. Patents for specific drug formulations and manufacturing processes can vary significantly.
Can generic versions of Diclofenac Sodium EC be made?
Once patents expire and regulatory approvals are obtained, generic versions of diclofenac sodium extended-release can be manufactured and marketed. This often leads to lower drug costs.
What are the risks associated with NSAIDs like Diclofenac Sodium EC?
NSAIDs, including diclofenac sodium EC, carry a risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke. They can also cause serious gastrointestinal bleeding, ulceration, and perforation. Individuals with pre-existing heart conditions, a history of ulcers, or kidney disease should use NSAIDs with caution and under medical supervision [2].
What clinical data supports the use of Diclofenac Sodium EC?
Clinical trials have demonstrated the efficacy of diclofenac sodium extended-release in reducing pain and improving function in patients with inflammatory conditions like osteoarthritis and rheumatoid arthritis. Data often focuses on pain reduction scores, joint swelling, and patient-reported outcomes [4].
Where can I find more information on Diclofenac Sodium EC patents and exclusivity?
Detailed information on patents, exclusivity periods, and potential market entry for generic competitors can be accessed through resources like DrugPatentWatch.com [3].